ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
41.02
0.61%
US Tech 100
21,158.40
-0.18%
S&P 500
6,084.19
0.82%
US Dollar vs CAD
1.41348
-0.11%
Bitcoin
100,932.94
-0.26%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Ironwood Pharmaceuticals Inc (IRWD)

  7. Ironwood Pharmaceuticals Inc (IRWD) News

IRWD

Ironwood Pharmaceuticals (IRWD)

Ironwood Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IRWD
DateTimeSourceHeadlineSymbolCompany
12/05/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRWDIronwood Pharmaceuticals Inc
11/26/20243:01PMBusiness WireIronwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:IRWDIronwood Pharmaceuticals Inc
11/20/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
11/20/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
11/15/20243:10PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
11/15/20243:07PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
11/14/20242:31PMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:IRWDIronwood Pharmaceuticals Inc
11/13/20243:01PMBusiness WireIronwood Pharmaceuticals to Participate in the Jefferies London Healthcare ConferenceNASDAQ:IRWDIronwood Pharmaceuticals Inc
11/12/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRWDIronwood Pharmaceuticals Inc
11/07/20244:22PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IRWDIronwood Pharmaceuticals Inc
11/07/20246:07AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRWDIronwood Pharmaceuticals Inc
11/07/20246:00AMBusiness WireIronwood Pharmaceuticals Reports Third Quarter 2024 ResultsNASDAQ:IRWDIronwood Pharmaceuticals Inc
10/28/20246:00AMBusiness WireOnce-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2024NASDAQ:IRWDIronwood Pharmaceuticals Inc
10/24/20243:00PMBusiness WireIronwood Pharmaceuticals to Host Third Quarter 2024 Investor Update CallNASDAQ:IRWDIronwood Pharmaceuticals Inc
10/23/20244:04PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:IRWDIronwood Pharmaceuticals Inc
09/30/20246:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRWDIronwood Pharmaceuticals Inc
08/29/20243:01PMBusiness WireIronwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare ConferenceNASDAQ:IRWDIronwood Pharmaceuticals Inc
08/14/20244:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
08/14/20244:08PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
08/09/20243:05PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
08/08/20243:06PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IRWDIronwood Pharmaceuticals Inc
08/08/20246:07AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRWDIronwood Pharmaceuticals Inc
08/08/20246:00AMBusiness WireIronwood Pharmaceuticals Reports Second Quarter 2024 ResultsNASDAQ:IRWDIronwood Pharmaceuticals Inc
07/25/20243:00PMBusiness WireIronwood Pharmaceuticals to Host Second Quarter 2024 Investor Update CallNASDAQ:IRWDIronwood Pharmaceuticals Inc
06/12/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
06/10/20243:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
06/10/20243:57PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
06/07/202412:35PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
06/06/20242:57PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
05/30/20243:01PMBusiness WireIronwood Pharmaceuticals to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:IRWDIronwood Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:IRWD

Your Recent History

NASDAQ
LWLG
Lightwave Logic
USOTC
GTCH
GBT Technologies (PK)
USOTC
PSRU
Valiant Eagle (PK)
NASDAQ
NXPL
NextPlat
NASDAQ
FCEL
FuelCell Energy
USOTC
VDRM
ViaDerma (PK)
USOTC
ASII
Accredited Solutions (PK)
USOTC
AXXA
Exxe (PK)
USOTC
AABB
Asia Broadband (PK)
USOTC
CGAC
Code Green Apparel (PK)
NASDAQ
TSLA
Tesla
USOTC
KRTL
KRTL (PK)
USOTC
QSEP
QS Energy (PK)
USOTC
ERHE
ERHC Energy (CE)
USOTC
RDGL
Vivos (QB)
USOTC
SINC
Sincerity Applied Materi... (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved